Evidence map›Paper›PMID 32891137›Full record

ArticleBMC public health2020

Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities.

Minttu M Rönn, Richard Dunville, Li Yan Wang, Meghan Bellerose, Yelena Malyuta, Nicolas A Menzies, Maria Aslam, Felicia Lewis, Cherie Walker-Baban, Lenore Asbel and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Minttu M RönnDepartment of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, USA. mronn@hsph.harvard.edu.ORCID http://orcid.org/0000-0002-9292-5670
Richard DunvilleDivision of Adolescent and School Health, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Li Yan WangDivision of Adolescent and School Health, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Meghan BelleroseDepartment of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, USA.
Yelena MalyutaDepartment of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, USA.
Nicolas A MenziesDepartment of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, USA.
Maria AslamOffice of the Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and PreventionPrevention, Atlanta, USA.
Felicia LewisDivision of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, USA.
Cherie Walker-BabanSTD Control Program, Philadelphia Department of Public Health, Philadelphia, PA, USA.
Lenore AsbelSTD Control Program, Philadelphia Department of Public Health, Philadelphia, PA, USA.
Sarah ParchemBureau of Maternal, Infant, Child, and Adolescent Health, Chicago Department of Public Health, Chicago, USA.
Lisa MasinterBureau of Maternal, Infant, Child, and Adolescent Health, Chicago Department of Public Health, Chicago, USA.
Ernestina PerezOffice of Student Health and Wellness, Chicago Public Schools, Chicago, USA.
Tom L GiftDivision of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, USA.
Katherine HsuDivision of STD Prevention & HIV/AIDS Surveillance, Massachusetts Department of Public Health, Jamaica Plain, USA.
Lisa C BarriosDivision of Adolescent and School Health, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Joshua A SalomonCenter for Health Policy / Center for Primary Care and Outcomes Research, Stanford University, Stanford, USA.
Centers for Disease Control and Prevention · USHarvard Global Health Institute · USChicago Department of Public Health · USPhiladelphia Department of Public Health · USChicago Public Schools · USHarvard University · USMassachusetts Department of Public Health · USStanford University · US

Funding

CDC HHS 5NU38PS004644
6 · The paper itself

Abstract

backgroundChlamydia screening in high schools offers a way to reach adolescents outside of a traditional clinic setting. Using transmission dynamic modeling, we examined the potential impact of high-school-based chlamydia screening programs on the burden of infection within intervention schools and surrounding communities, under varying epidemiological and programmatic conditions.

methodsA chlamydia transmission model was calibrated to epidemiological data from three different settings. Philadelphia and Chicago are two high-burden cities with existing school-based screening programs. Rural Iowa does not have an existing program but represents a low-burden setting. We modeled the effects of the two existing programs to analyze the potential influence of program coverage and student participation. All three settings were used to examine a broader set of hypothetical programs with varying coverage levels and time trends in participation.

resultsIn the modeled Philadelphia program, prevalence among the intervention schools' sexually active 15-18 years old population was 4.34% (95% credible interval 3.75-4.71%)after 12 program years compared to 5.03% (4.39-5.43%) in absence of the program. In the modeled Chicago program, prevalence was estimated as 5.97% (2.60-7.88%) after 4 program years compared to 7.00% (3.08-9.29%) without the program. In the broader hypothetical scenarios including both high-burden and low-burden settings, impact of school-based screening programs was greater in absolute terms in the higher-prevalence settings, and benefits in the community were approximately proportional to population coverage of intervention schools. Most benefits were garnered if the student participation did not decline over time.

conclusionsSustained high student participation in school-based screening programs and broad coverage of schools within a target community are likely needed to maximize program benefits in terms of reduced burden of chlamydia in the adolescent population.

Indexed as

Chlamydia trachomatisMass ScreeningSchool Health ServicesSchoolsStudentsAdolescentChicagoChlamydia InfectionsFemaleHumansIowaMaleModels, TheoreticalPatient Acceptance of Health CarePhiladelphiaPrevalenceAdolescent healthChlamydiaScreening

Identifiers

PMID32891137
PMCPMC7487537
OpenAlexW3083037423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.